| 000 | 01783 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516044613.0 | ||
| 264 | 0 | _c20111122 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1464-3405 | ||
| 024 | 7 |
_a10.1016/j.bmcl.2011.06.045 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKerns, Jeffrey K | |
| 245 | 0 | 0 |
_aAzepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cAug 2011 |
||
| 300 |
_a4409-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlanine _xchemistry |
| 650 | 0 | 4 |
_aAzepines _xchemical synthesis |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aCathepsin K _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCathepsin L _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCathepsins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aProtease Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aNie, Hong | |
| 700 | 1 | _aBondinell, William | |
| 700 | 1 | _aWiddowson, Katherine L | |
| 700 | 1 | _aYamashita, Dennis S | |
| 700 | 1 | _aRahman, Attiq | |
| 700 | 1 | _aPodolin, Patricia L | |
| 700 | 1 | _aCarpenter, Donald C | |
| 700 | 1 | _aJin, Qi | |
| 700 | 1 | _aRiflade, Benoit | |
| 700 | 1 | _aDong, Xiaoyang | |
| 700 | 1 | _aNevins, Neysa | |
| 700 | 1 | _aKeller, Paul M | |
| 700 | 1 | _aMitchell, Laura | |
| 700 | 1 | _aTomaszek, Thaddeus | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 21 _gno. 15 _gp. 4409-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2011.06.045 _zAvailable from publisher's website |
| 999 |
_c20986117 _d20986117 |
||